BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bergantini L, d'Alessandro M, Vietri L, Rana GD, Cameli P, Acerra S, Sestini P, Bargagli E. Utility of serological biomarker' panels for diagnostic accuracy of interstitial lung diseases. Immunol Res 2020;68:414-21. [PMID: 33089426 DOI: 10.1007/s12026-020-09158-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Sánchez-díez S, Munoz X, Ojanguren I, Romero-mesones C, Espejo D, Villar A, Gómez-olles S, Cruz M. YKL-40 and KL-6 Levels in Serum and Sputum of Patients Diagnosed With Hypersensitivity Pneumonitis. The Journal of Allergy and Clinical Immunology: In Practice 2022;10:2414-2423. [DOI: 10.1016/j.jaip.2022.06.031] [Reference Citation Analysis]
2 Korenromp IH, Maier LA, Grutters JC. Sarcoidosis: serum and imaging biomarkers. Sarcoidosis 2022. [DOI: 10.1183/2312508x.10031720] [Reference Citation Analysis]
3 Rana GD, d'Alessandro M, Rizzi L, Bergantini L, Cameli P, Vozza A, Sestini P, Suppressa P, Bargagli E. Clinical phenotyping in sarcoidosis management. Sarcoidosis Vasc Diffuse Lung Dis 2021;38:e2021007. [PMID: 34316252 DOI: 10.36141/svdld.v38i2.10423] [Reference Citation Analysis]
4 Melani AS, Simona A, Armati M, d'Alessandro M, Bargagli E. A Comprehensive Review of Sarcoidosis Diagnosis and Monitoring for the Pulmonologist. Pulm Ther 2021. [PMID: 34091831 DOI: 10.1007/s41030-021-00161-w] [Reference Citation Analysis]
5 d'Alessandro M, Soccio P, Bergantini L, Cameli P, Scioscia G, Foschino Barbaro MP, Lacedonia D, Bargagli E. Extracellular Vesicle Surface Signatures in IPF Patients: A Multiplex Bead-Based Flow Cytometry Approach. Cells 2021;10:1045. [PMID: 33925174 DOI: 10.3390/cells10051045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
6 Aoshima Y, Enomoto Y, Muto S, Meguro S, Kawasaki H, Kosugi I, Fujisawa T, Enomoto N, Inui N, Nakamura Y, Suda T, Iwashita T. Gremlin-1 for the Differential Diagnosis of Idiopathic Pulmonary Fibrosis Versus Other Interstitial Lung Diseases: A Clinical and Pathophysiological Analysis. Lung 2021;199:289-98. [PMID: 33770226 DOI: 10.1007/s00408-021-00440-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
7 d'Alessandro M, Bellisai F, Bergantini L, Cameli P, D'Alessandro R, Mazzei MA, Gentili F, Conticini E, Selvi E, Frediani B, Matucci-Cerinic M, Bargagli E. Prognostic role of KL-6 in SSc-ILD patients with pleuroparenchymal fibroelastosis. Eur J Clin Invest 2021;51:e13543. [PMID: 33759179 DOI: 10.1111/eci.13543] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
8 d'Alessandro M, Bergantini L, Cameli P, Fanetti M, Alderighi L, Armati M, Refini RM, Alonzi V, Sestini P, Bargagli E. Immunologic responses to antifibrotic treatment in IPF patients. Int Immunopharmacol 2021;95:107525. [PMID: 33714885 DOI: 10.1016/j.intimp.2021.107525] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
9 d'Alessandro M, Bergantini L, Cameli P, Pieroni M, Refini RM, Sestini P, Bargagli E. Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy. Cancers (Basel) 2021;13:689. [PMID: 33572070 DOI: 10.3390/cancers13040689] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
10 d'Alessandro M, Bergantini L, Torricelli E, Cameli P, Lavorini F, Pieroni M, Refini RM, Sestini P, Bargagli E. Systematic Review and Metanalysis of Oncomarkers in IPF Patients and Serial Changes of Oncomarkers in a Prospective Italian Real-Life Case Series. Cancers (Basel) 2021;13:539. [PMID: 33572642 DOI: 10.3390/cancers13030539] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
11 Yoon T, Ahn SS, Yoo J, Song JJ, Park YB, Lee SW. Serum Amyloid A Is a Biomarker of Disease Activity and Health-Related Quality-of-Life in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Dis Markers 2020;2020:8847306. [PMID: 33488845 DOI: 10.1155/2020/8847306] [Reference Citation Analysis]